Elicio Therapeutics
Price & Volume
Stats
See moreOpen | $11.13 |
Previous Close | $11.14 |
Day Range | $11.04-$11.15 |
52W Range | $4.05-$12.62 |
Market Cap | $184.9M |
Shares Short | 465,308 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$3.98 |
News
See moreYahoo Finance • 6 days ago
Elicio Therapeutics Reports Inducement Grants
Yahoo Finance • last month
Elicio Therapeutics Announces Publication of ELI-002 Updated AMPLIFY-201 Phase 1 Follow-up Data in Nature Medicine for Minimal Residual Disease (“MRD”) Positive, Adjuvant-Stage Patients
Yahoo Finance • 2 months ago
Elicio (ELTX) Q2 Loss Beats Estimates
Yahoo Finance • 2 months ago
Unlocking Oncology’s Future: 3 Trending Cancer Biotech Stocks with ‘Strong Buy’ Ratings
About
CEO | Mr. Robert T. Connelly |
Address | 451 D Street, Boston, MA, United States, 02210 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 32 |
